News Daily News FDA Investigating Possible Sex Differences in LAAO Outcomes Todd Neale September 27, 2021
News Daily News Cumulative Burden of LDL Cholesterol Increases CHD Risk Michael O'Riordan September 23, 2021
News Daily News Renal Denervation a Third Option for Hypertension, European Experts Say Todd Neale September 17, 2021
News Daily News Switching to Tenecteplase for Stroke Thrombolysis May Boost Outcomes Todd Neale September 09, 2021
News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2021 STEP Trial Supports Lower BP Goal in Older Patients With Hypertension Todd Neale August 30, 2021
News Conference News ESC 2021 Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD Michael O'Riordan August 29, 2021
News Conference News ESC 2021 Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’ L.A. McKeown August 28, 2021
News Conference News ESC 2021 Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD Michael O'Riordan August 28, 2021
News Conference News ESC 2021 SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI Michael O'Riordan August 27, 2021
News Daily News Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2 Michael O'Riordan August 26, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Daily News Endpoint Reporting in Medical Journals Needs to Be Revamped: Review Michael O'Riordan August 17, 2021
News Daily News Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD L.A. McKeown August 10, 2021
News Daily News Milrinone, Dobutamine Comparable for Cardiogenic Shock: DOREMI Todd Neale August 10, 2021